Filing Details

Accession Number:
0001209191-10-010510
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-18 12:00:00
Reporting Period:
2010-02-17
Filing Date:
2010-02-18
Accepted Time:
2010-02-18 17:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1156295 Seracare Life Sciences Inc SRLS In Vitro & In Vivo Diagnostic Substances (2835) 330056054
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1390820 David Olsen C/O Seracare Life Sciences, Inc.
37 Birch Street
Milford MA 01757
V.p., Corporate Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-17 4,000 $3.46 5,028 No 4 S Direct
Common Stock Disposition 2010-02-18 4,478 $3.55 550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct